SAIK ANDREW (EVP & Chief Financial Officer) reported 1 transaction at INTERCEPT PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/23/2023ACC: 0001104659-23-074233
Officer· EVP & Chief Financial Officer
Since Jun 2021
-908.00
Net shares
Net seller
$10.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
908.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−908.00
Price / share
$11.74
Trade value
$10.66K
% of position
1.3%
6/21/2023
70.08K→69.17K
Total
Net shares
−908.00
Net value
-$10.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/21/2023 | F · Tax Withholding | −908.00 | $11.74 | $10.66K | 1.3% | 70.08K | 69.17K |
| Total | −908.00 | -$10.66K | ||||||
Derivative Transactions0
No derivative transactions reported